GlassScriptPhysician profile
William D Brearley
NPI 1639208671
$10,173.49
in general payments reported to CMS, 2019-2025
43 companies · $1,365 in 2025
The $1,365 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,615 · 2020: $506 · 2021: $902 · 2022: $1,545 · 2023: $2,173 · 2024: $2,067 · 2025: $1,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,604.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,882.57 | 2019-2025 | |
| Medtronic, INC. | $1,400.43 | 2021-2025 | Linq II, Micra, Selectsecure |
| Boston Scientific Corporation | $1,041.47 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Watchman Flx |
| Amgen INC. | $941.41 | 2019-2025 | Repatha, Repatha |
| Inari Medical, INC. | $680.99 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $554.30 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Abbott Laboratories | $404.84 | 2020-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $366.26 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $360.46 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $353.69 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $221.25 | 2019-2023 | Kengreal |
| Janssen Pharmaceuticals, INC | $198.60 | 2019-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $178.12 | 2019-2023 | |
| Shockwave Medical, INC | $156.51 | 2022 | |
| Medtronic Vascular, INC. | $150.76 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Brearley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.